Skip to content

Therapeutic Effect of Acupuncture and Pelvic Floor Electrophysiological Stimulation on Patients with Urinary Retention after Radical Resection of Cervical Cancer

Obstetrics and Gynecology

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ITMCTR
Registry ID
ITMCTR2200005505
Enrollment
Unknown
Registered
2022-01-05
Start date
2022-02-01
Completion date
Unknown
Last updated
2023-02-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

urinary retention

Interventions

Sponsors

Obstetrics & Gynecology Hospital of Fudan University
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
20 Years to 60 Years

Inclusion criteria

Inclusion criteria: 1. Cervical cancer stage Ib1-IIa2 (2009 FIGO cervical cancer clinical staging) patients of 20-60 years old who have urinary retention after the catheter is removed 14-60 days after radical hysterectomy, whose residual urine is more than 100ml measured for two consecutive days. 2. The operation record confirmed that the operation method was radical hysterectomy; 3. Patients whoes expected survival time is more than 12 months; 4. Patients who agree to participate in this trial and have signed an informed consent form.

Exclusion criteria

Exclusion criteria: 1. Patients who have received pelvic radiotherapy in the past; 2. Patients older than 60 years old or younger than 20 years old; 3. Patients who undergo radical hysterectomy which have not been confirmed by surgery and pathology; 4. Patients with previous symptoms such as urinary dysfunction, urinary incontinence, or abnormal preoperative urodynamic tests; 5. Patients with severe urinary tract infection or vesicovaginal fistula; 6. Patients who are in the acute stage of other diseases: impaired consciousness, body temperature greater than 38°C, unstable vital signs or acute abdomen, etc.; 7. Patients who have important organ function impairment: liver enzymes> 2 times the upper limit of normal, creatinine> 2 times the upper limit of normal, blood amylase> 2 times the upper limit of normal, heart function grade 3-4, etc.; 8. Patients who have brain disease or abnormal judgment ability; 9. Patients who have drug and/or alcohol abuse; 10. Patients with mental illness receiving medication; 11. Patients who participated in other clinical trials within 4 weeks before the start of this study.

Design outcomes

Primary

MeasureTime frame
urodynamic measurement;urine routine;residual urine;

Countries

China

Contacts

Public ContactYun Wang

Obstetrics & Gynecology Hospital of Fudan University

yunwang0621@163.com13764418392

Outcome results

None listed

Source: ITMCTR (via WHO ICTRP) · Data processed: Feb 4, 2026